Prenetics Global Ltd. (PRE) Danny Yeung, CEO

A leading healthsciences company, is dedicated to advancing consumer and clinical health. Ourconsumer initiatives is led by IM8, a new health and wellness brand. Ourclinical division is led by Insighta, our $200million joint venture with renowned scientist Prof. Dennis Lo, focused on multi-cancer early detectiontechnologies. This is followed by ACT Genomics, which has achieved FDAclearance for comprehensive genomic profiling of solid tumors, and CircleDNA,which uses NGS to offer comprehensive DNA tests. Each of Prenetics' unitssynergistically enhances our global impact on health, embodying our commitmentto 'enhancing life through science'.